ELDN - Eledon Pharmaceuticals - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-33.27M

Cash

71.38M

Avg Qtr Burn

-8.049M

Short % of Float

0.29%

Insider Ownership

6.10%

Institutional Own.

29.52%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Tegoprubart (AT-1501) Details Amyotrophic lateral sclerosis	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Tegoprubart (AT-1501) Details Renal Transplantation	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Tegoprubart (AT-1501) Details Type 1 diabetes, Islet Cell Transplantation	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Tegoprubart (AT-1501) Details Autoimmune nephritis	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Tegoprubart (AT-1501) Details IgA nephropathy	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.